Feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced biliary tract cancer with carcinomatous ascites.

Trial Profile

Feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced biliary tract cancer with carcinomatous ascites.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Mar 2012

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel; Paclitaxel
  • Indications Biliary cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top